016057890	016057890	CD	B-NP	O
|	|	NN	I-NP	O
SMC	SMC	NN	I-NP	O
|	|	NN	I-NP	O
57637683	57637683	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
4322944	4322944	CD	B-NP	O
|	|	CC	I-NP	O
10/10/2004	10/10/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
7/6/2004	7/6/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/22/2004	9/22/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
DILEO	DILEO	NNP	B-NP	O
,	,	,	O	O
DOUGLASS	DOUGLASS	NNP	B-NP	O
W.	W.	NNP	I-NP	O
256-96-78-3	256-96-78-3	CD	I-NP	O
W71	W71	NNP	I-NP	O
Room	Room	NNP	I-NP	O
:	:	:	O	O
00E-984	00E-984	NNP	B-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
10/22/04	10/22/04	CD	B-NP	O
AT	AT	NN	I-NP	O
04	04	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
ambulatory	ambulatory	JJ	I-NP	O
O2	O2	NN	I-NP	O
sat	sit	VBD	B-VP	O
>	>	SYM	B-NP	O
90	90	CD	B-NP	O
%	%	NN	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
KLOKE	KLOKE	NNP	B-NP	O
,	,	,	O	O
BRADLEY	BRADLEY	NNP	B-NP	O
RICHIE	RICHIE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
3/18/04	3/18/04	CD	B-NP	O
by	by	IN	B-PP	O
PHELP	PHELP	NN	B-NP	B-protein
,	,	,	O	O
RYAN	RYAN	NNP	B-NP	O
KENNETH	KENNETH	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
PO	PO	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
33758314	33758314	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
tolerates	tolerate	VBZ	B-VP	O
Previous	Previous	NNP	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
6/28/04	6/28/04	CD	B-NP	O
by	by	IN	B-PP	O
PUCIO	PUCIO	NNP	B-NP	O
,	,	,	O	O
JERROLD	JERROLD	NNP	B-NP	O
GERMAN	GERMAN	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ENTERIC	ENTERIC	NNP	B-NP	O
COATED	COATED	NNP	I-NP	O
ASA	ASA	NNP	I-NP	O
PO	PO	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
QD	QD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
63903616	63903616	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
reason	reason	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/30/04	10/30/04	CD	B-NP	O
by	by	IN	B-PP	O
SWENK	SWENK	NN	B-NP	B-protein
,	,	,	O	O
RILEY	RILEY	NNP	B-NP	O
RICKY	RICKY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
PH.D.	PH.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
37111878	37111878	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
patient	patient	NN	B-NP	O
takes	take	VBZ	B-VP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	B-DNA
INSULIN	INSULIN	NN	I-NP	I-DNA
NPH	NPH	NN	I-NP	I-DNA
HUMAN	HUMAN	NN	I-NP	I-DNA
36	36	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
;	;	:	O	I-DNA
40	40	CD	B-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	I-DNA
SC	SC	NNP	I-NP	I-DNA
36	36	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QAM	QAM	NNP	I-NP	I-DNA
40	40	CD	I-NP	I-DNA
UNITS	UNITS	NNP	I-NP	I-DNA
QPM	QPM	NNP	I-NP	O
NEURONTIN	NEURONTIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
GABAPENTIN	GABAPENTIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PLAVIX	PLAVIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ZETIA	ZETIA	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EZETIMIBE	EZETIMIBE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
PREVACID	PREVACID	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LANSOPRAZOLE	LANSOPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
GLUCOPHAGE	GLUCOPHAGE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
IBUPROFEN	IBUPROFEN	NNP	I-NP	O
600-800	600-800	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/22/04	10/22/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
IBUPROFEN	IBUPROFEN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
95935140	95935140	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
PROBABLE	PROBABLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
has	have	VBZ	B-VP	O
tolerated	tolerate	VBN	I-VP	O
in	in	IN	B-PP	O
past	past	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/22/04	10/22/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
CLOPIDOGREL	CLOPIDOGREL	NNP	B-NP	O
BISULFATE	BISULFATE	NNP	I-NP	O
&	&	CC	I-NP	O
IBUPROFEN	IBUPROFEN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Monitoring	Monitor	VBG	B-VP	O
HCT	HCT	NN	B-NP	B-DNA
ATENOLOL	ATENOLOL	NN	I-NP	I-DNA
25	25	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
take	take	VB	B-VP	O
1/2	1/2	CD	B-NP	O
your	your	PRP$	B-NP	O
regular	regular	JJ	I-NP	O
home	home	NN	I-NP	O
dose	dose	NN	I-NP	O
until	until	IN	B-SBAR	O
you	you	PRP	B-NP	O
see	see	VBP	B-VP	O
your	your	PRP$	B-NP	O
cardiologist/PCP	cardiologist/PCP	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Brechbiel	Brechbiel	NNP	I-NP	O
his	his	PRP$	B-NP	O
office	office	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
re	re	VB	B-VP	O
:	:	:	O	O
appointment	appointment	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
Dr.	Dr.	NNP	B-NP	O
Damms	Damms	NNP	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
is	be	VBZ	B-VP	O
setting	set	VBG	I-VP	O
up	up	RP	B-PRT	O
right	right	JJ	B-NP	O
leg	leg	NN	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
for	for	IN	B-PP	O
2-4	2-4	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NN	B-NP	B-protein
,	,	,	O	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
SHELLFISH	SHELLFISH	NN	B-NP	O
,	,	,	O	O
Codeine	Codeine	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
unstable	unstable	JJ	I-NP	O
angina	angina	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
diabetes	diabete	VBZ	B-VP	O
-LRB-	-LRB-	NNP	B-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
s/p	s/p	NN	I-NP	O
stent	stent	JJ	I-NP	O
placement	placement	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
S/P	S/P	NN	I-NP	O
angioplasty	angioplasty	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
high	high	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
cholesterol	cholesterol	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
htn	htn	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
fibromyalgia	fibromyalgia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
gallstones	gallstone	NNS	I-NP	O
-LRB-	-LRB-	VBP	B-VP	O
biliary	biliary	JJ	B-NP	O
stones	stone	NNS	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
6/28/04	6/28/04	CD	B-NP	O
Cardiac	Cardiac	JJ	I-NP	O
cath	cath	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
64	64	CD	B-NP	O
y/o	y/o	NN	I-NP	O
F	F	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
OM1	OM1	NN	I-NP	I-protein
stent	stent	NN	I-NP	I-protein
'99	'99	CD	I-NP	I-protein
,	,	,	O	O
w	w	NN	B-NP	O
/	/	SYM	B-NP	O
1	1	CD	I-NP	O
month	month	NN	I-NP	O
h/o	h/o	NN	I-NP	O
worsened	worsen	VBD	B-VP	O
exertional	exertional	JJ	B-NP	O
angina	angina	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
jaw	jaw	NN	I-NP	O
tightness	tightness	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
2	2	CD	B-NP	O
day	day	NN	I-NP	O
h/o	h/o	NN	I-NP	O
worsening	worsen	VBG	B-VP	O
intermittent	intermittent	JJ	B-NP	O
jaw	jaw	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
SOB	SOB	NN	B-NP	B-protein
,	,	,	O	O
presented	present	VBN	B-VP	O
after	after	IN	B-PP	O
2nd	2nd	JJ	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
pain	pain	NN	B-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
to	to	TO	B-PP	O
G	G	NNP	B-NP	O
ED	ED	NNP	I-NP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
enzymes	enzyme	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
heparinized	heparinize	VBN	I-VP	O
for	for	IN	B-PP	O
EKG	EKG	NN	B-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
PMBMC	PMBMC	NN	B-NP	O
ED	ED	NN	I-NP	O
where	where	WRB	B-ADVP	O
B-set	B-set	JJ	B-NP	O
TnI	TnI	NN	I-NP	O
positive	positive	JJ	B-ADJP	O
;	;	:	O	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
leads	lead	NNS	I-NP	O
.	.	.	O	O

Cath	Cath	NN	B-NP	O
results	result	NNS	I-NP	O
below	below	IN	B-ADVP	O
.	.	.	O	O

Initial	Initial	JJ	B-NP	O
exam	exam	NN	I-NP	O
-	-	HYPH	B-NP	O
BP	BP	NN	I-NP	O
140s	140	NNS	I-NP	O
,	,	,	O	O
HR	HR	NN	B-NP	B-DNA
50s	50s	CD	I-NP	I-DNA
,	,	,	O	O
afebrile	afebrile	JJ	B-NP	O
,	,	,	I-NP	O
soft	soft	JJ	I-NP	O
systolic	systolic	JJ	I-NP	O
murmur	murmur	NN	I-NP	O
,	,	,	O	O
clear	clear	JJ	B-NP	O
lungs	lung	NNS	I-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
-	-	HYPH	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
TWI	TWI	NN	B-NP	O
in	in	IN	B-PP	O
anterior	anterior	JJ	B-NP	O
leads	lead	NNS	I-NP	O
,	,	,	O	O
Troponin	Troponin	NN	B-NP	B-protein
0.67	0.67	CD	I-NP	I-protein
,	,	,	O	O
MB	MB	NN	B-NP	B-protein
7.4	7.4	CD	I-NP	I-protein
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
303	303	CD	I-NP	I-cell_line
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
303	303	CD	I-NP	I-cell_line
.	.	.	O	O

HCT	HCT	NN	B-NP	O
39.1	39.1	CD	I-NP	O
PMHx	PMHx	NN	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
Om1	Om1	NN	I-NP	O
stent	stent	NN	I-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
fibromyalgia	fibromyalgia	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
CCY	CCY	NN	I-NP	O
,	,	,	O	O
spinal	spinal	JJ	B-NP	O
stenosis	stenosis	NN	I-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
s/p	s/p	NN	B-NP	O
TAH	TAH	NNP	I-NP	O
**	**	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
Course	Course	NNP	I-NP	O
**	**	NNP	I-NP	O
CV/HEME	CV/HEME	NNP	I-NP	O
:	:	:	O	O
Patient	Patient	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
on	on	IN	B-PP	O
6/28/04	6/28/04	CD	B-NP	O
-	-	HYPH	I-NP	O
LAD	LAD	NN	I-NP	O
90	90	CD	I-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
and	and	CC	O	O
OM2	OM2	NN	B-NP	O
99	99	CD	B-NP	O
%	%	NN	I-NP	O
lesion	lesion	NN	I-NP	O
both	both	CC	O	O
successfully	successfully	RB	B-VP	O
stented	stente	VBD	I-VP	O
with	with	IN	B-PP	O
cypher	cypher	NN	B-NP	O
.	.	.	O	O

Remaining	Remain	VBG	B-VP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
PDA	PDA	NN	I-NP	O
.	.	.	O	O

Following	Follow	VBG	B-PP	O
cath	cath	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
had	have	VBD	B-VP	O
bradycardia	bradycardia	NN	B-NP	O
to	to	TO	B-PP	O
20-30	20-30	CD	B-NP	O
's	's	POS	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
femoral	femoral	JJ	B-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

BP	BP	NN	B-NP	O
initially	initially	RB	B-VP	O
measured	measure	VBN	I-VP	O
in	in	IN	B-PP	O
60s	60	NNS	B-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
vagal	vagal	JJ	B-NP	O
2/2	2/2	CD	I-NP	O
femoral	femoral	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

Received	Receive	VBN	B-NP	O
atropine	atropine	NN	I-NP	O
x	x	SYM	B-NP	O
1	1	CD	I-NP	O
and	and	CC	O	O
Fem	Fem	NNP	B-NP	O
stop	stop	NN	I-NP	O
placed	place	VBD	B-VP	O
over	over	IN	B-PP	O
cath	cath	NN	B-NP	O
site	site	NN	I-NP	O
for	for	IN	B-PP	O
compression	compression	NN	B-NP	O
-	-	HYPH	B-NP	O
BP	BP	NN	I-NP	O
dropped	drop	VBD	B-VP	O
again	again	RB	B-ADVP	O
with	with	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
-	-	HYPH	O	O
transferred	transfer	VBN	B-VP	O
to	to	TO	B-PP	O
CCU	CCU	NN	B-NP	B-DNA
and	and	CC	I-NP	O
briefly	briefly	NN	I-NP	O
on	on	IN	B-PP	O
dopamine	dopamine	NN	B-NP	O
.	.	.	O	O

CT	CT	NN	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
retroperitoneal	retroperitoneal	JJ	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

Hct	Hct	NN	B-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Transferred	Transfer	VBD	B-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
within	within	IN	B-PP	O
24	24	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
occasional	occasional	JJ	B-NP	O
mild	mild	JJ	I-NP	O
abdominal	abdominal	JJ	I-NP	O
discomfort	discomfort	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
had	have	VBD	B-VP	O
negative	negative	JJ	B-NP	O
LFTs	LFT	NNS	I-NP	O
and	and	CC	I-NP	O
lipase	lipase	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
also	also	RB	B-ADVP	O
noted	note	VBD	B-VP	O
right	right	JJ	B-NP	O
calf	calf	NN	I-NP	O
pain	pain	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
below-the	below-the	JJ	I-NP	O
knee	knee	NN	I-NP	O
right	right	JJ	I-NP	O
tibial	tibial	JJ	I-NP	O
vein	vein	NN	I-NP	O
DVT	DVT	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
anticoagulated	anticoagulate	VBN	I-VP	O
for	for	IN	B-PP	O
this	this	DT	B-NP	O
below-the	below-the	JJ	I-NP	O
knee	knee	NN	I-NP	O
clot	clot	NN	I-NP	O
because	because	IN	B-PP	O
of	of	IN	I-PP	O
low	low	JJ	B-NP	O
risk	risk	NN	I-NP	O
of	of	IN	B-PP	O
embolization	embolization	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
r	r	VBP	B-VP	O
recent	recent	JJ	B-NP	O
HCT	HCT	NN	I-NP	O
drop/hematoma	drop/hematoma	NN	I-NP	O
.	.	.	O	O

LENI	LENI	NN	B-NP	B-protein
was	be	VBD	B-VP	O
repeated	repeat	VBN	I-VP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
progression	progression	NN	I-NP	O
.	.	.	O	O

One	One	CD	B-NP	O
the	the	DT	B-NP	O
two	two	CD	I-NP	O
days	day	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
HCT	HCT	NN	I-NP	O
dropped	drop	VBD	B-VP	O
from	from	IN	B-PP	O
32	32	CD	B-NP	O
to	to	TO	B-PP	O
26	26	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
trandfused	trandfuse	VBN	I-VP	O
2	2	CD	B-NP	O
U	U	NN	I-NP	O
PRBC	PRBC	NN	I-NP	O
w/HCT	w/HCT	NN	I-NP	O
bump	bump	NN	I-NP	O
to	to	TO	B-PP	O
34.1	34.1	CD	B-NP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
shrinkage	shrinkage	NN	B-NP	O
of	of	IN	B-PP	O
hematoma	hematoma	NN	B-NP	O
,	,	,	O	O
so	so	RB	B-ADJP	O
pt	pt	JJ	I-ADJP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
with	with	IN	B-PP	O
plans	plan	NNS	B-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
PCP	PCP	NN	B-NP	O
recheck	recheck	NN	I-NP	O
HCT	HCT	NN	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

MSK	MSK	NN	B-NP	B-protein
:	:	:	O	O
Patient	Patient	NN	B-NP	O
complained	complain	VBD	B-VP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
knee	knee	NN	I-NP	O
pain	pain	NN	I-NP	O
after	after	IN	B-PP	O
fall	fall	NN	B-NP	O
one	one	CD	B-NP	O
week	week	NN	I-NP	O
prior	prior	RB	B-ADVP	O
.	.	.	O	O

X-ray	X-ray	NN	B-NP	O
shoed	shoe	VBD	B-VP	O
only	only	RB	B-NP	O
osteoarthritis	osteoarthritis	NN	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
knee	knee	NN	B-NP	O
was	be	VBD	B-VP	O
somewhat	somewhat	RB	B-ADJP	O
warm	warm	JJ	I-ADJP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
clear	clear	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
so	so	IN	B-SBAR	O
patient	patient	NN	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
given	give	VBN	I-VP	O
ibuprofen	ibuprofen	NN	B-NP	O
PRN	PRN	NN	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
.	.	.	O	O

______	______	LS	B-NP	O
Anti-ischemic	Anti-ischemic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
at	at	IN	B-PP	O
discharge	discharge	NN	B-NP	O
:	:	:	O	O
ASA	ASA	NNP	B-NP	O
,	,	,	O	O
Plavix	Plavix	NNP	B-NP	O
,	,	,	O	O
Atenolol	Atenolol	NNP	B-NP	O
,	,	,	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	PDT	B-NP	B-protein
no	no	DT	I-NP	O
Statin	Statin	NN	I-NP	B-protein
because	because	IN	B-PP	O
of	of	IN	I-PP	O
muscle	muscle	NN	B-NP	B-protein
pain	pain	NN	I-NP	I-protein
hx	hx	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Will	Will	MD	B-VP	O
continue	continue	VB	I-VP	O
home	home	NN	B-NP	O
diabetic	diabetic	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	I-NP	O
followup	followup	NN	I-NP	O
with	with	IN	B-PP	O
PCP/cardiology	PCP/cardiology	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
return	return	VB	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
or	or	CC	O	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
or	or	CC	O	O
difficulty	difficulty	NN	B-NP	O
breathing	breathing	NN	I-NP	O
.	.	.	O	O

Dr.	Dr.	NNP	B-NP	O
Estrello	Estrello	NNP	I-NP	O
's	's	POS	B-NP	O
office	office	NN	I-NP	O
will	will	MD	B-VP	O
send	send	VB	I-VP	O
someone	someone	NN	B-NP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
home	home	NN	I-NP	O
on	on	IN	B-PP	O
Sunday	Sunday	NNP	B-NP	O
8/17	8/17	CD	I-NP	O
to	to	TO	B-VP	O
draw	draw	VB	I-VP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
today	today	NN	B-NP	O
is	be	VBZ	B-VP	O
34.1	34.1	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
repeat	repeat	NN	I-NP	B-protein
right	right	JJ	I-NP	I-protein
leg	leg	NN	I-NP	I-protein
ultrasound	ultrasound	NN	I-NP	I-protein
test	test	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
``	``	``	I-NP	O
LENI	LENI	NNP	I-NP	O
''	''	''	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
the	the	DT	B-NP	O
small	small	JJ	I-NP	O
blood	blood	NN	I-NP	O
clot	clot	NN	I-NP	O
in	in	IN	B-PP	O
your	your	PRP$	B-NP	O
leg	leg	NN	I-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
schedule	schedule	VB	I-VP	O
this	this	DT	B-NP	O
test	test	NN	I-NP	O
to	to	TO	B-VP	O
occur	occur	VB	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
next	next	JJ	I-NP	O
3-4	3-4	CD	I-NP	O
weeks	week	NNS	I-NP	O
through	through	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Gino	Gino	NNP	I-NP	O
Onisick	Onisick	NNP	I-NP	O
office	office	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MILLISOR	MILLISOR	NNP	B-NP	O
,	,	,	O	O
JERE	JERE	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.S.	M.S.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
QL28	QL28	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/22/04	10/22/04	CD	I-NP	O
@	@	SYM	B-NP	O
05	05	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

